logo

For the Inventor, By the Inventor

Burlingame, CA, United States of America

Pankaj Garg

This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignee: Twist Bioscience Corporation. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pankaj Garg. Retrieved from https://idiyas.com/inventor/pankaj-garg-bf5o5jxi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal6 out of 76 
 
Twist Bioscience Corporation
 patents

Years Active: 2022-2026

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12570750 - ANTIBODIES THAT BIND ADENOSINE A2A RECEPTORS AND METHODS OF USE THEREOF TO TREAT CANCER AND NEUROLOGICAL DISEASES (2026-03-10),
2. 12391762 - Methods and compositions relating to GLP1R variants (2025-08-19),
3. 12331427 - Antibodies that bind GLP1R (2025-06-17),
4. 12173282 - Antibodies that bind CD3 epsilon (2024-12-24),
5. 12091777 - Variant nucleic acid libraries for CRTH2 (2024-09-17),
6. 11492727 - Variant nucleic acid libraries for GLP1 receptor (2022-11-08),

Title: Pankaj Garg: Innovator in GLP1R Research

Introduction

Pankaj Garg is a notable inventor based in Burlingame, CA, who has made significant contributions to the field of biotechnology. With a focus on glucagon-like peptide-1 receptor (GLP1R) variants, he has developed innovative methods and compositions that advance our understanding of this important receptor.

Latest Patents

Pankaj Garg holds five patents, with his latest innovations centered around methods and compositions relating to GLP1R variants. These patents include libraries of nucleic acids encoding immunoglobulins that bind to GLP1R, as well as variegated libraries that comprise nucleic acids encoding predetermined variants of reference nucleic acid sequences. Additionally, he has developed protein libraries generated from these nucleic acid libraries and cell libraries expressing the variegated nucleic acid libraries.

Career Highlights

Pankaj Garg is currently employed at Twist Bioscience Corporation, where he continues to push the boundaries of research in GLP1R. His work is instrumental in the development of therapeutic applications that could potentially improve health outcomes related to metabolic disorders.

Collaborations

Some of Pankaj's coworkers include Aaron Sato and Qiang Liu, who collaborate with him on various projects within the company. Their combined expertise contributes to the innovative environment at Twist Bioscience Corporation.

Conclusion

Pankaj Garg's contributions to GLP1R research exemplify the impact of innovative thinking in biotechnology. His patents and ongoing work at Twist Bioscience Corporation highlight the importance of collaboration and creativity in advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…